Blood biomarkers may spot ectopic pregnancies early

NCT ID NCT03877939

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at whether certain molecules in the blood (kisspeptins and miRNAs) can help diagnose non-viable pregnancies, including ectopic pregnancies. Researchers collected blood samples from 433 women to measure these biomarkers. The goal is to develop a more accurate and earlier diagnostic test for these dangerous conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to identify non-viable pregnancies early, potentially reducing maternal risks.

What could go wrong

This is a completed observational study, not a treatment trial. The biomarkers need further validation before any clinical test becomes available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-VIABLE PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ectopic pregnancy pregnancy disorder with abortive outcome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IVI RMA Madrid

    Madrid, Madrid, 28023, Spain

  • IVI RMA Seville

    Seville, Seville, 41011, Spain